AC Immune SA (FRA:IMR)

AC Immune Statistics

Total Valuation

AC Immune has a market cap or net worth of EUR 233.20 million. The enterprise value is 121.22 million.

Market Cap	233.20M
Enterprise Value	121.22M

Important Dates

The next estimated earnings date is Friday, March 13, 2026.

Earnings Date	Mar 13, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	98.94M
Shares Outstanding	n/a
Shares Change (YoY)	+4.26%
Shares Change (QoQ)	+0.26%
Owned by Insiders (%)	2.99%
Owned by Institutions (%)	5.03%
Float	39.29M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	49.90
PB Ratio	3.49
P/TBV Ratio	18.14
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-1.58
EV / Sales	25.70
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-2.38

Financial Position

The company has a current ratio of 1.16, with a Debt / Equity ratio of 0.07.

Current Ratio	1.16
Quick Ratio	1.12
Debt / Equity	0.07
Debt / EBITDA	n/a
Debt / FCF	-0.10
Interest Coverage	-408.24

Financial Efficiency

Return on equity (ROE) is -74.63% and return on invested capital (ROIC) is -45.59%.

Return on Equity (ROE)	-74.63%
Return on Assets (ROA)	-21.97%
Return on Invested Capital (ROIC)	-45.59%
Return on Capital Employed (ROCE)	-99.66%
Revenue Per Employee	30,543
Profits Per Employee	-502,099
Employee Count	172
Asset Turnover	0.02
Inventory Turnover	n/a

Taxes

In the past 12 months, AC Immune has paid 3,207 in taxes.

Income Tax	3,207
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -17.97% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-17.97%
50-Day Moving Average	2.69
200-Day Moving Average	1.98
Relative Strength Index (RSI)	43.91
Average Volume (20 Days)	711

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	5.52

Income Statement

In the last 12 months, AC Immune had revenue of EUR 4.67 million and -76.82 million in losses. Loss per share was -0.77.

Revenue	4.67M
Gross Profit	-61.17M
Operating Income	-78.11M
Pretax Income	-76.82M
Net Income	-76.82M
EBITDA	-76.59M
EBIT	-78.11M
Loss Per Share	-0.77

Balance Sheet

The company has 115.94 million in cash and 4.98 million in debt, giving a net cash position of 110.96 million.

Cash & Cash Equivalents	115.94M
Total Debt	4.98M
Net Cash	110.96M
Net Cash Per Share	n/a
Equity (Book Value)	66.74M
Book Value Per Share	0.66
Working Capital	16.52M

Cash Flow

In the last 12 months, operating cash flow was -50.04 million and capital expenditures -943,817, giving a free cash flow of -50.99 million.

Operating Cash Flow	-50.04M
Capital Expenditures	-943,817
Free Cash Flow	-50.99M
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	-1,671.43%
Pretax Margin	-1,643.82%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

AC Immune does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-4.26%
Shareholder Yield	-4.26%
Earnings Yield	-32.94%
FCF Yield	-21.86%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

AC Immune has an Altman Z-Score of -3.57 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-3.57
Piotroski F-Score	1